Dr. John Campbell | Severe Illness After Vaxx
2 K Views
23
Hospitalisation among vaccine breakthrough COVID-19 infections
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00558-2/fulltextRobust vaccine efficacies at preventing severe symptomatic diseaseBreakthrough SARS-CoV-2 infections in fully vaccinated.
https://covid.joinzoe.com/post/worryingly-close-to-100-000-new-cases-a-day
Impact of vaccination on admission to hospital.
Patients with confirmed SARS-CoV-2 infection.
Yale New Haven Health System, Connecticut.
Between March 23 and July 1, 2021 Patients were considered fully vaccinated 14 days after second dose.
969 patients were admitted PCR positive.
172 (18%) of 969 patients had received at least one vaccine dose.
103 had received a partial vaccine course.
15 had received a complete course.
54 were fully vaccinated.
Among the 54.
25 (46%) patients were asymptomatic.
4 (7%) had mild disease.
11 (20%) had moderate disease.
14 (26%) had severe or critical illness.
4 (7%) required ICU.
1 required ventilation.
3 died.
Among those with severe or critical illness.
Median age 80·5 years.
Pre-existing comorbidities in the 14 patients with severe or critical illness.
Body–mass index more than 25 kg/m² (n=9).
Cardiovascular disease (n=12).
Lung disease (n=7).
Malignancy (n=4).
Type 2 diabetes (n=7).
Immunosuppressive agent (n=4).
Difference between vaccines.
13 of 14 patients had received BNT162b2, Pfizer.
1 of the 14 had received mRNA-1273, Moderna.
0 of the 14 had received Ad.26. COV2.S, J and J.
May 17, 2021, vaccine doses in Connecticut.
Pfizer, 1,358,175.
Moderna, 1,044,420.
J and J, 267,000 .
This Content Is Mirrored. Please support the original creator. All credit, royalties and sincere thanks to the original source of this video. https://www.youtube.com/watch?v=vOyB2PyRf-k - October 31, 2021
Dr. John Campbell | Severe Illness After Vaxx
Dr. John Campbell, Severe Illness After Vaxx, October 31 2021
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00558-2/fulltextRobust vaccine efficacies at preventing severe symptomatic diseaseBreakthrough SARS-CoV-2 infections in fully vaccinated.
https://covid.joinzoe.com/post/worryingly-close-to-100-000-new-cases-a-day
Impact of vaccination on admission to hospital.
Patients with confirmed SARS-CoV-2 infection.
Yale New Haven Health System, Connecticut.
Between March 23 and July 1, 2021 Patients were considered fully vaccinated 14 days after second dose.
969 patients were admitted PCR positive.
172 (18%) of 969 patients had received at least one vaccine dose.
103 had received a partial vaccine course.
15 had received a complete course.
54 were fully vaccinated.
Among the 54.
25 (46%) patients were asymptomatic.
4 (7%) had mild disease.
11 (20%) had moderate disease.
14 (26%) had severe or critical illness.
4 (7%) required ICU.
1 required ventilation.
3 died.
Among those with severe or critical illness.
Median age 80·5 years.
Pre-existing comorbidities in the 14 patients with severe or critical illness.
Body–mass index more than 25 kg/m² (n=9).
Cardiovascular disease (n=12).
Lung disease (n=7).
Malignancy (n=4).
Type 2 diabetes (n=7).
Immunosuppressive agent (n=4).
Difference between vaccines.
13 of 14 patients had received BNT162b2, Pfizer.
1 of the 14 had received mRNA-1273, Moderna.
0 of the 14 had received Ad.26. COV2.S, J and J.
May 17, 2021, vaccine doses in Connecticut.
Pfizer, 1,358,175.
Moderna, 1,044,420.
J and J, 267,000 .
This Content Is Mirrored. Please support the original creator. All credit, royalties and sincere thanks to the original source of this video. https://www.youtube.com/watch?v=vOyB2PyRf-k - October 31, 2021
Dr. John Campbell | Severe Illness After Vaxx
Dr. John Campbell, Severe Illness After Vaxx, October 31 2021